Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Other Working Capital Changes: 2016-2025

Historic Other Working Capital Changes for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $30.6 million.

  • Tg Therapeutics' Other Working Capital Changes rose 19.72% to $30.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year increase of 90.05%. This contributed to the annual value of -$2.3 million for FY2020, which is 63.08% down from last year.
  • According to the latest figures from Q3 2025, Tg Therapeutics' Other Working Capital Changes is $30.6 million, which was up 482.36% from $5.3 million recorded in Q2 2025.
  • Tg Therapeutics' 5-year Other Working Capital Changes high stood at $30.6 million for Q3 2025, and its period low was -$6.8 million during Q1 2022.
  • Over the past 3 years, Tg Therapeutics' median Other Working Capital Changes value was $2.6 million (recorded in 2023), while the average stood at $5.8 million.
  • Per our database at Business Quant, Tg Therapeutics' Other Working Capital Changes slumped by 1,272.86% in 2023 and then skyrocketed by 2,339.18% in 2024.
  • Over the past 5 years, Tg Therapeutics' Other Working Capital Changes (Quarterly) stood at $1.3 million in 2021, then tumbled by 127.06% to -$339,000 in 2022, then slumped by 1,272.86% to -$4.7 million in 2023, then decreased by 19.55% to -$5.6 million in 2024, then grew by 19.72% to $30.6 million in 2025.
  • Its Other Working Capital Changes stands at $30.6 million for Q3 2025, versus $5.3 million for Q2 2025 and $4.6 million for Q1 2025.